Evidence map›Paper›PMID 25673831›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice.

Dena B Dubal, Lei Zhu, Pascal E Sanchez, Kurtresha Worden, Lauren Broestl, Erik Johnson, Kaitlyn Ho, Gui-Qiu Yu, Daniel Kim, Alexander Betourne and 4 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 200 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The first 25 years of the Northwestern University SuperAging Program.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Dena B DubalGladstone Institute of Neurological Disease, San Francisco, California 94158, Department of Neurology, University of California, San Francisco, California 94158, dena.dubal@ucsf.edu lmucke@gladstone.ucsf.edu.
Lei ZhuGladstone Institute of Neurological Disease, San Francisco, California 94158, Department of Neurology, University of California, San Francisco, California 94158.
Pascal E SanchezGladstone Institute of Neurological Disease, San Francisco, California 94158, Department of Neurology, University of California, San Francisco, California 94158.
Kurtresha WordenGladstone Institute of Neurological Disease, San Francisco, California 94158, Department of Neurology, University of California, San Francisco, California 94158.ORCID http://orcid.org/0000-0001-5621-7979
Lauren BroestlDepartment of Neurology, University of California, San Francisco, California 94158.
Erik JohnsonGladstone Institute of Neurological Disease, San Francisco, California 94158, Department of Neurology, University of California, San Francisco, California 94158.
Kaitlyn HoGladstone Institute of Neurological Disease, San Francisco, California 94158.
Gui-Qiu YuGladstone Institute of Neurological Disease, San Francisco, California 94158.
Daniel KimGladstone Institute of Neurological Disease, San Francisco, California 94158.
Alexander BetourneDepartment of Neurology, University of California, San Francisco, California 94158.
Makoto Kuro-ODepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390.
Eliezer MasliahDepartments of Neurosciences and Pathology, University of California, San Diego, San Diego, California 92093, and.
Carmela R AbrahamDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118.
Lennart MuckeGladstone Institute of Neurological Disease, San Francisco, California 94158, Department of Neurology, University of California, San Francisco, California 94158, dena.dubal@ucsf.edu lmucke@gladstone.ucsf.edu.
Gladstone Institutes · USUniversity of California, San Francisco · USBoston University · USThe University of Texas Southwestern Medical Center · USUniversity of San Diego · US

Funding

VIRUS-INDUCED BRAIN PATHOLOGYP50AG005131 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MASLIAH, ELIEZER · 1985 to 2018
$55.4M
Viral VectorsP01AG010435 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TUSZYNSKI, MARK H. · 1991 to 2014
$20.9M
STRUCTURAL STUDIES IN THE CENTRAL NERVOUS SYSTEMP01AG000001 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 1985 to 2013
$20.7M
Roles of Amyloid Precursor Protein and its Metabolites in Neuronal ImpairmentR01NS041787 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI MUCKE, LENNART · 2001 to 2015
$6.9M
B-Synuclein as a Treatment for Lewy Body DiseaseR01AG018440 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RISSMAN, ROBERT · 2001 to 2021
$5.2M
Effects of Klotho Protein on Aging and MetabolismR01AG019712 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI KURO-O, MAKOTO · 2002 to 2011
$4.1M
Behavioral CoreP30NS065780 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI MUCKE, LENNART · 2011 to 2015
$4.0M
Neurobiology and Therapeutic Potential of KlothoR01NS088532 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI MUCKE, LENNART · 2014 to 2018
$3.5M
a-synuclein clearance strategies for the treatment of Lewy body disease.R37AG018440 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MASLIAH, ELIEZER · 2006 to 2014
$2.7M
Collagen VI: Novel Mechanisms and Functions in Alzheimer's DiseaseK08AG034531 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUBAL, DENA BOU · 2009 to 2013
$540k
NCRR NIH HHS RR18938-01NIA NIH HHS AG000001NIA NIH HHS AG010435NIA NIH HHS AG019712NIA NIH HHS AG034531NIA NIH HHS AG18440NIA NIH HHS K08 AG034531NIA NIH HHS P01 AG000001NIA NIH HHS P01 AG010435NIA NIH HHS P50 AG005131NIA NIH HHS R01 AG018440NIA NIH HHS R01 AG019712NIA NIH HHS R37 AG018440NINDS NIH HHS NS041787NINDS NIH HHS NS065780NINDS NIH HHS NS088532NINDS NIH HHS P30 NS065780NINDS NIH HHS R01 NS041787NINDS NIH HHS R01 NS088532
6 · The paper itself

Abstract

Aging is the principal demographic risk factor for Alzheimer disease (AD), the most common neurodegenerative disorder. Klotho is a key modulator of the aging process and, when overexpressed, extends mammalian lifespan, increases synaptic plasticity, and enhances cognition. Whether klotho can counteract deficits related to neurodegenerative diseases, such as AD, is unknown. Here we show that elevating klotho expression decreases premature mortality and network dysfunction in human amyloid precursor protein (hAPP) transgenic mice, which simulate key aspects of AD. Increasing klotho levels prevented depletion of NMDA receptor (NMDAR) subunits in the hippocampus and enhanced spatial learning and memory in hAPP mice. Klotho elevation in hAPP mice increased the abundance of the GluN2B subunit of NMDAR in postsynaptic densities and NMDAR-dependent long-term potentiation, which is critical for learning and memory. Thus, increasing wild-type klotho levels or activities improves synaptic and cognitive functions, and may be of therapeutic benefit in AD and other cognitive disorders.

Indexed as

Amyloid beta-Protein PrecursorAnimalsBehavior, AnimalCognitionCognition DisordersGlucuronidaseHumansKlotho ProteinsLongevityMaze LearningMiceMice, TransgenicNerve NetReceptors, N-Methyl-D-AspartateSynapsestau ProteinsAmyloid beta-Protein PrecursorGlucuronidaseKlotho ProteinsReceptors, N-Methyl-D-Aspartatetau ProteinsagingAlzheimer's diseasecognitionklothomiceNMDA receptors

Identifiers

PMID25673831
PMCPMC4323521
OpenAlexW2065401361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.